Replies to post #764828 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

This is better than ASCO 2025‼️

[Doc logic]

norisknorewards,

You may want to think about the last keynote speech on that agenda too.
Antoni Ribas MD, PHD, University of California Los Angeles

KEYNOTE ADDRESS: How The Immune System Can Treat Cancer

Best wishes.

[learningcurve2020]

“Next generation”.

[antihama]

Good find. Let's play it again Sam! Rumor has it, this remake will be much better than the 1st version. I wonder if his name was a later addition since, while he's listed in the Agenda, he is not listed under the list of speakers...yet. While his session is only 15 min, there is a half hr break afterwards so I can see his session going a little into overtime.

[Investor082]

Super interesting that NWBO is not busy for this but too busy for ASCO, LOL! ;)

Will Dr. Bosch be presenting at NYAS in person?

[meirluc]

Having skipped the early June ASCO meeting because of the need to
have all hands on deck, NWBO's Marnix Bosch finds the time to present on
June 16 at NYAS, a 15 minute Industry Blitz session entitled "Next Generation
Dendritic Cell Treatments To Improve Anti-Tumor Responses". Could that imply that
NWBO perhaps expects MAA approval to arrive before June 16 because even
a 15 minute presentation may require much time and effort if all hands are
still required to be on deck.

Furthermore, wouldn't you think that when MB talks about the tumor response
efficacy of the next generation of dendritic cells, he would have an advantage if
the MHRA had already submitted its MAA approval that underlines that the first
generation of dendritic cells already possesses a substantial degree of efficacy?

Bottom line: Is MB's presentation suggestive of an MAA approval before June 16?